1979
DOI: 10.1016/s0022-5223(19)38262-5
|View full text |Cite
|
Sign up to set email alerts
|

Coronary bypass in a patient with hemophilia B, or Christmas disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
13
0

Year Published

1983
1983
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 33 publications
0
13
0
Order By: Relevance
“…There are several case reports and case series of percutaneous coronary stent insertion and of cardiac surgery in patients with haemophilia A [8][9][10][11][12][13][14] and haemophilia B [11,[15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30]. Some of the older reports describe perioperative haemostatic strategies that are now outdated, such as plasmapheresis with fresh frozen plasma replacement [17] and reliance on prothrombin complex concentrate [16,18,21].…”
Section: Discussion and Review Of The Literaturementioning
confidence: 99%
“…There are several case reports and case series of percutaneous coronary stent insertion and of cardiac surgery in patients with haemophilia A [8][9][10][11][12][13][14] and haemophilia B [11,[15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30]. Some of the older reports describe perioperative haemostatic strategies that are now outdated, such as plasmapheresis with fresh frozen plasma replacement [17] and reliance on prothrombin complex concentrate [16,18,21].…”
Section: Discussion and Review Of The Literaturementioning
confidence: 99%
“…Reference lists of original articles were also reviewed. In addition, an extensive search 25 Chronic viral infections with known atheromatic activity including chronic hepatitis C virus 10,16 and human immunodeficiency virus 9,12 were also reported.…”
Section: Review Of the Literaturementioning
confidence: 99%
“…4,7,9 The first reported cases of PWH A were transfused pre-operatively with fresh frozen plasma (FFP) and/or cryoprecipitate 26 and PWH B with FFP and/or prothrombin complex concentrate (PCC). [23][24][25] Except for factor replacement, other hemostatic agents were rarely used as an adjuvant therapy to control blood loss. During CABG the antifibrinolytics that were given were aminocaproid acid, 9,19,22 aprotinin, 11,21 and trans-4-aminomethylcyclohexanecarboxylic acid (tranexamid acid).…”
Section: Review Of the Literaturementioning
confidence: 99%
See 2 more Smart Citations